Jotec GmbH
Clinical trials sponsored by Jotec GmbH, explained in plain language.
Now part of
Artivion, Inc.
AORT
NYSE
A medical device company specializing in vascular implants, acquired by CryoLife.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Researchers check safety of stent grafts used in aortic aneurysm surgery Results expected Sep 2026 (estimated)